Ascent Wealth Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $669K | Sell |
3,414
-80
| -2% | -$15.5K | 0.08% | 130 |
|
|
2025
Q4 | $606K | Sell |
3,494
-440
| -11% | -$80.1K | 0.07% | 130 |
|
|
2025
Q3 | $750K | Hold |
3,934
| – | – | 0.09% | 124 |
|
|
2025
Q2 | $707K | Sell |
3,934
-2,077
| -35% | -$361K | 0.09% | 123 |
|
|
2025
Q1 | $1.02M | Buy |
6,011
+1,990
| +49% | +$327K | 0.14% | 114 |
|
|
2024
Q4 | $607K | Sell |
4,021
-64
| -2% | -$9.95K | 0.08% | 119 |
|
|
2024
Q3 | $634K | Sell |
4,085
-32
| -0.8% | -$4.78K | 0.09% | 115 |
|
|
2024
Q2 | $564K | Sell |
4,117
-329
| -7% | -$45.1K | 0.08% | 124 |
|
|
2024
Q1 | $592K | Buy |
4,446
+20
| +0.5% | +$2.6K | 0.09% | 124 |
|
|
2023
Q4 | $610K | Buy |
4,426
+48
| +1% | +$6.31K | 0.1% | 122 |
|
|
2023
Q3 | $534K | Buy |
4,378
+313
| +8% | +$41.7K | 0.1% | 122 |
|
|
2023
Q2 | $571K | Buy |
4,065
+1,982
| +95% | +$273K | 0.1% | 122 |
|
|
2023
Q1 | $295K | Sell |
2,083
-7
| -0.3% | -$1K | 0.06% | 136 |
|
|
2022
Q4 | $327K | Sell |
2,090
-243
| -10% | -$34.9K | 0.07% | 129 |
|
|
2022
Q3 | $286K | Sell |
2,333
-1,518
| -39% | -$200K | 0.07% | 123 |
|
|
2022
Q2 | $512K | Sell |
3,851
-49
| -1% | -$6.68K | 0.12% | 111 |
|
|
2022
Q1 | $534K | Buy |
3,900
+1,555
| +66% | +$217K | 0.1% | 111 |
|
|
2021
Q4 | $406K | Sell |
2,345
-1,722
| -42% | -$262K | 0.07% | 120 |
|
|
2021
Q3 | $591K | Buy |
4,067
+36
| +0.9% | +$5.27K | 0.11% | 114 |
|
|
2021
Q2 | $532K | Buy |
4,031
+103
| +3% | +$13.5K | 0.1% | 107 |
|
|
2021
Q1 | $504K | Sell |
3,928
-23,177
| -86% | -$2.86M | 0.11% | 93 |
|
|
2020
Q4 | $3.23M | Buy |
27,105
+225
| +0.8% | +$27.4K | 0.72% | 45 |
|
|
2020
Q3 | $3.08M | Buy |
26,880
+278
| +1% | +$32.8K | 0.79% | 43 |
|
|
2020
Q2 | $3.03M | Buy |
26,602
+1,305
| +5% | +$138K | 0.88% | 40 |
|
|
2020
Q1 | $2.03M | Buy |
25,297
+30
| +0.1% | +$3.11K | 0.74% | 46 |
|
|
2019
Q4 | $2.7M | Buy |
25,267
+289
| +1% | +$30.1K | 0.77% | 44 |
|
|
2019
Q3 | $2.67M | Sell |
24,978
-120
| -0.5% | -$12.3K | 0.82% | 44 |
|
|
2019
Q2 | $2.56M | Buy |
25,098
+435
| +2% | +$41.8K | 0.79% | 44 |
|
|
2019
Q1 | $2.22M | Buy |
24,663
+2,648
| +12% | +$229K | 0.72% | 46 |
|
|
2018
Q4 | $1.83M | Sell |
22,015
-3,883
| -15% | -$364K | 0.72% | 48 |
|
|
2018
Q3 | $2.79M | Buy |
25,898
+512
| +2% | +$56.2K | 0.89% | 43 |
|
|
2018
Q2 | $2.79M | Buy |
25,386
+113
| +0.4% | +$11.8K | 0.98% | 38 |
|
|
2018
Q1 | $2.54M | Buy |
25,273
+838
| +3% | +$85.8K | 0.92% | 44 |
|
|
2017
Q4 | $2.41M | Buy |
+24,435
| New | +$2.32M | 0.9% | 45 |
|
|
2017
Q3 | – | Sell |
-1,871
| Closed | -$208K | – | 122 |
|
|
2017
Q2 | $208K | Buy |
+1,871
| New | +$198K | 0.09% | 116 |
|
Other funds holding DGX
VCM
VPM
EIG
Ascent Wealth Partners's DGX Position: Q1 2026 in Review
Ascent Wealth Partners reduced its Quest Diagnostics (DGX) stake by 2.3% in Q1 2026, selling an estimated $15.5K and leaving 3,414 shares worth $669K. The position accounts for 0.08% of the portfolio, ranked #130.
Ascent Wealth Partners first reported a position in DGX in Q2 2017 and has held it in 35 quarters since. The position peaked at $3.23M in Q4 2020. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Ascent Wealth Partners held 3,414 shares of Quest Diagnostics worth $669K as of Q1 2026.
- Ascent Wealth Partners sold 80 Quest Diagnostics shares in Q1 2026, an estimated $15.5K.
- Quest Diagnostics made up 0.08% of Ascent Wealth Partners's portfolio in Q1 2026, its #130 holding.
- Ascent Wealth Partners first reported a position in Quest Diagnostics in Q2 2017 and has held it in 35 quarters since.
- Ascent Wealth Partners's Quest Diagnostics position peaked at $3.23M in Q4 2020.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Ascent Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.